Veraxa Biotech AG - Ordinary Shares (NQ:VRXA)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
96.0% below 52-week high
1.090
1.0452W Low
27.3652W High
1 Week
17.4% below 1-week high
1.041W Low
1.321W High
Veraxa Biotech AG - Ordinary Shares (VRXA) traded between $1.04 and $27.36 over the past 52 weeks and last traded at $1.09, 96.0% below its 52-week high. Over the past week it ranged between $1.04 and $1.32.
Past 12 Months
1W
-$0.04
1M
-$0.51
3M
-$1.39
6M
-$23.70
YTD
-$23.70
1Y
-$23.70
VRXA was -95.6% over the past year, -95.6% over six months, -95.6% year to date, -3.5% in the last week.
12 Months vs Market
VRXA
DIA
SPY
QQQ
IWM
Over the past 12 months VRXA returned -95.6% versus DIA (Dow) +10.0%, SPY (S&P 500) +15.3%, QQQ (Nasdaq 100) +22.9% and IWM (Russell 2000) +12.7%.
Volume & Liquidity
0.11× 3-mo avg
Today 30,645
3-mo avg 274.0K
1W
1M
3M
6M
YTD
1Y
VRXA most recently traded 30,645 shares against a 3-month average daily volume of 274.0K. More NewsRead More
These stocks are moving in today's session ↗
September 04, 2026
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
September 04, 2026
Frequently Asked QuestionsIs Veraxa Biotech AG - Ordinary Shares publicly traded?
Yes, Veraxa Biotech AG - Ordinary Shares is publicly traded.
What exchange does Veraxa Biotech AG - Ordinary Shares trade on?
Veraxa Biotech AG - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Veraxa Biotech AG - Ordinary Shares?
The ticker symbol for Veraxa Biotech AG - Ordinary Shares is VRXA on the Nasdaq Stock Market
What is the current price of Veraxa Biotech AG - Ordinary Shares?
The current price of Veraxa Biotech AG - Ordinary Shares is 1.090
When was Veraxa Biotech AG - Ordinary Shares last traded?
The last trade of Veraxa Biotech AG - Ordinary Shares was at 10/09/26 09:37 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
